Skip to main content
. Author manuscript; available in PMC: 2022 Mar 6.
Published in final edited form as: Cell Rep. 2022 Feb 15;38(7):110358. doi: 10.1016/j.celrep.2022.110358

Figure 4. The molecular signature of CISR is present in Parkinson’s disease.

Figure 4.

(A–D) ZIP14, TFRC, and HAMP mRNA levels are significantly increased in the SN of patients with PD by qPCR analysis. n = 5 patients per group.

(E–I) ZIP14, TFRC, and DMT1 protein levels are increased in the SN of patients with PD, whereas FPN protein levels are decreased by western analysis. n = 5 patients per group. Data indicate mean ± SEM. *p < 0.05, **p < 0.01 by unpaired student’s two-tailed t test.